1. Regeneron says antibody cocktail prevents/treats coronavirus in animal studies — FDA turns back DBV Technolgies' peanut allergy patch — Amarin to launch Vascepa by itself in Europe — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

BMS selling off Zymo??

Discussion in 'Zymogenetics' started by Anonymous, May 13, 2011 at 8:45 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Scuttlebutt is that BMS doesn't like so-called idiots in Seattle and is going to sell them off!!
     

  2. Anonymous

    Anonymous Guest

    Lets have Zymo merge with Endo to form a new company called ZYMOENDO. It's has a great sound to it. Slips right off your tongue. Or reverse it........ENDOZYMO and give it a Sesame Street jingle jangle! Tow companies run by a group of spacial ( not special) muppet brains. They really deserve each other, don't you think?
     
  3. Anonymous

    Anonymous Guest

    Lets have Zymo merge with Endo to form a new company called ZYMOENDO. It's has a great sound to it. Slips right off your tongue. Or reverse it........ENDOZYMO and give it a Sesame Street jingle jangle! Tow companies run by a group of spacial ( not special) muppet brains. They really deserve each other, don't you think?
     
  4. Anonymous

    Anonymous Guest

    LMFAO!! :D